April 15, 2019 / 4:14 AM / 5 months ago

BUZZ-India's Wockhardt up; co says U.S. FDA inspection yields no observations

** Shares of drugmaker Wockhardt Ltd rise as much as 2.3 pct to 460 rupees, their highest since April 8

** Co says no observations made after U.S. FDA inspects its Bioequivalence centre in Aurangabad, Maharashtra

** Bioequivalence studies of Tamsulosin 0.4mg capsules and Metoprolol Tartrate 200mg ER tablets were audited - co

** About 425,970 shares change hands in less than half an hour into trading compared with the 30-day average volume of around 1.9 mln

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below